RAJAF (Cordyceps Sunshine Biotech Holdings Co) ROE % Adjusted to Book Value : Negative Equity% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co ROE % Adjusted to Book Value?

Cordyceps Sunshine Biotech Holdings Co's ROE % for the quarter that ended in Dec. 2023 was Negative Equity. Cordyceps Sunshine Biotech Holdings Co's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was Negative Equity.

Cordyceps Sunshine Biotech Holdings Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co ROE % Adjusted to Book Value Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Negative Equity

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	-	Negative Equity

Competitive Comparison of Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value

For the Packaged Foods subindustry, Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value falls into.

Cordyceps Sunshine Biotech Holdings Co ROE % Adjusted to Book Value Calculation

Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	Negative Equity	/	N/A
	=	Negative Equity

Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	Negative Equity	/	N/A
	=	Negative Equity

Cordyceps Sunshine Biotech Holdings Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cordyceps Sunshine Biotech Holdings Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordyceps Sunshine Biotech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN

Website

http://www.cordyceps-sunshine.com

Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines